Goldman Sachs
EVAR

Goldman Sachs’s Lombard Medical, Inc. EVAR Stock Holding History

Goldman Sachs’s Portfolio EVAR Stock Details EVAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-15,800
Closed -$7K – 6923
2017
Q3 		$7K Sell
15,800
-6,434
-29% -$3.15K ﹤0.01% 6559
2017
Q2 		$12K Sell
22,234
-316
-1% -$165 ﹤0.01% 6640
2017
Q1 		$18K Hold
22,550
– – ﹤0.01% 6541
2016
Q4 		$14K Sell
22,550
-1,055
-4% -$823 ﹤0.01% 6721
2016
Q3 		$22K Sell
23,605
-3,036
-11% -$3.22K ﹤0.01% 6733
2016
Q2 		$29K Sell
26,641
-4,977
-16% -$6.92K ﹤0.01% 6605
2016
Q1 		$33K Buy
31,618
+13,323
+73% +$11.9K ﹤0.01% 6595
2015
Q4 		$25K Buy
18,295
+2,495
+16% +$5.9K ﹤0.01% 6798
2015
Q3 		$56K Hold
15,800
– – ﹤0.01% 6749
2015
Q2 		$70K Sell
15,800
-199,900
-93% -$916K ﹤0.01% 6770
2015
Q1 		$869K Buy
215,700
+199,900
+1,265% +$1.03M ﹤0.01% 4612
2014
Q4 		$103K Hold
15,800
– – ﹤0.01% 6562
2014
Q3 		$122K Sell
15,800
-600
-4% -$3.97K ﹤0.01% 6490
2014
Q2 		$118K Buy
+16,400
New +$134K ﹤0.01% 6488

Other funds holding EVAR

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Goldman Sachs's EVAR Position: Q4 2017 in Review

Goldman Sachs sold out of Lombard Medical, Inc. (EVAR) in Q4 2017, closing a stake of 15,800 shares — an estimated $7K sold.

Goldman Sachs first reported a position in EVAR in Q2 2014 and held it in 14 quarters. The position peaked at $869K in Q1 2015. 2 funds tracked by Wall St. Rank hold EVAR as of Q4 2017.

  • Goldman Sachs reported no remaining Lombard Medical, Inc. position as of Q4 2017 after selling out during the quarter.
  • Goldman Sachs sold 15,800 Lombard Medical, Inc. shares in Q4 2017, an estimated $7K.
  • Goldman Sachs first reported a position in Lombard Medical, Inc. in Q2 2014 and held it in 14 quarters.
  • Goldman Sachs's Lombard Medical, Inc. position peaked at $869K in Q1 2015.
  • 2 funds tracked by Wall St. Rank held Lombard Medical, Inc. as of Q4 2017.

Based on Goldman Sachs's 13F filing for Q4 2017, filed 14 Feb 2018.